Intrinsiqs

Is Guardant Health, Inc. overvalued?

Guardant Health, Inc. (GH) — key valuation metrics and fundamentals.

No verdict
Price
$160.94
Fair value
Current P/E
Normal P/E
Market cap
$21.60B
Dividend yield
0.0%
Return on equity
211.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.